Logo image of DPT.PA

S.T. DUPONT (DPT.PA) Stock Fundamental Analysis

EPA:DPT - Euronext Paris - Matif - FR0000054199 - Common Stock - Currency: EUR

0.0984  +0 (+1.23%)

Fundamental Rating

1

Overall DPT gets a fundamental rating of 1 out of 10. We evaluated DPT against 43 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of DPT is average, but there are quite some concerns on its profitability. DPT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DPT had negative earnings in the past year.
DPT had a negative operating cash flow in the past year.
DPT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DPT reported negative operating cash flow in multiple years.
DPT.PA Yearly Net Income VS EBIT VS OCF VS FCFDPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

DPT has a worse Return On Assets (-1.88%) than 79.07% of its industry peers.
The Return On Equity of DPT (-4.08%) is worse than 79.07% of its industry peers.
With a Return On Invested Capital value of 0.50%, DPT is not doing good in the industry: 83.72% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1.88%
ROE -4.08%
ROIC 0.5%
ROA(3y)-7.16%
ROA(5y)-13.62%
ROE(3y)-107.46%
ROE(5y)-111.33%
ROIC(3y)N/A
ROIC(5y)N/A
DPT.PA Yearly ROA, ROE, ROICDPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With a Operating Margin value of 0.47%, DPT is not doing good in the industry: 83.72% of the companies in the same industry are doing better.
DPT's Operating Margin has declined in the last couple of years.
DPT's Gross Margin of 55.91% is on the low side compared to the rest of the industry. DPT is outperformed by 65.12% of its industry peers.
DPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.47%
PM (TTM) N/A
GM 55.91%
OM growth 3YN/A
OM growth 5Y-37.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.1%
GM growth 5Y-0.81%
DPT.PA Yearly Profit, Operating, Gross MarginsDPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

DPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DPT has been increased compared to 1 year ago.
DPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DPT has an improved debt to assets ratio.
DPT.PA Yearly Shares OutstandingDPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DPT.PA Yearly Total Debt VS Total AssetsDPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

DPT has an Altman-Z score of 3.00. This indicates that DPT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.00, DPT is in line with its industry, outperforming 58.14% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that DPT is not too dependend on debt financing.
DPT has a Debt to Equity ratio of 0.30. This is in the better half of the industry: DPT outperforms 76.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3
ROIC/WACC0.06
WACC8.45%
DPT.PA Yearly LT Debt VS Equity VS FCFDPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.76 indicates that DPT should not have too much problems paying its short term obligations.
The Current ratio of DPT (1.76) is better than 69.77% of its industry peers.
A Quick Ratio of 1.02 indicates that DPT should not have too much problems paying its short term obligations.
The Quick ratio of DPT (1.02) is better than 69.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.02
DPT.PA Yearly Current Assets VS Current LiabilitesDPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

DPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -150.00%.
DPT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.82%.
The Revenue has been decreasing by -0.22% on average over the past years.
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y19.2%
Revenue growth 5Y-0.22%
Sales Q2Q%1.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DPT.PA Yearly Revenue VS EstimatesDPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
DPT.PA Price Earnings VS Forward Price EarningsDPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

DPT's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. DPT is more expensive than 88.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.09
DPT.PA Per share dataDPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

S.T. DUPONT

EPA:DPT (8/5/2025, 7:00:00 PM)

0.0984

+0 (+1.23%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners90.6%
Ins Owner ChangeN/A
Market Cap92.86M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.73
P/FCF N/A
P/OCF N/A
P/B 3.54
P/tB 3.71
EV/EBITDA 32.09
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.06
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.88%
ROE -4.08%
ROCE 0.68%
ROIC 0.5%
ROICexc 0.59%
ROICexgc 0.61%
OM 0.47%
PM (TTM) N/A
GM 55.91%
FCFM N/A
ROA(3y)-7.16%
ROA(5y)-13.62%
ROE(3y)-107.46%
ROE(5y)-111.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-33.76%
ROICexc growth 3YN/A
ROICexc growth 5Y-31.48%
OM growth 3YN/A
OM growth 5Y-37.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.1%
GM growth 5Y-0.81%
F-Score4
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 2.57
Cap/Depr 89.25%
Cap/Sales 4.7%
Interest Coverage 0.16
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.02
Altman-Z 3
F-Score4
WACC8.45%
ROIC/WACC0.06
Cap/Depr(3y)125.52%
Cap/Depr(5y)84.1%
Cap/Sales(3y)6.59%
Cap/Sales(5y)5.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.82%
Revenue growth 3Y19.2%
Revenue growth 5Y-0.22%
Sales Q2Q%1.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y188.38%
EBIT growth 3YN/A
EBIT growth 5Y-37.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-264.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-144.55%
OCF growth 3YN/A
OCF growth 5YN/A